First Horizon Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.23K | Hold |
516
| – | – | ﹤0.01% | 1766 |
|
|
2025
Q1 | $8.07K | Hold |
516
| – | – | ﹤0.01% | 1677 |
|
|
2024
Q4 | $7.19K | Hold |
516
| – | – | ﹤0.01% | 1714 |
|
|
2024
Q3 | $4.8K | Hold |
516
| – | – | ﹤0.01% | 1806 |
|
|
2024
Q2 | $4.8K | Sell |
516
-46
| -8% | -$428 | ﹤0.01% | 1770 |
|
|
2024
Q1 | $5.57K | Hold |
562
| – | – | ﹤0.01% | 1786 |
|
|
2023
Q4 | $1.82K | Hold |
562
| – | – | ﹤0.01% | 2053 |
|
|
2023
Q3 | $2.98K | Hold |
562
| – | – | ﹤0.01% | 1885 |
|
|
2023
Q2 | $5.36K | Hold |
562
| – | – | ﹤0.01% | 1771 |
|
|
2023
Q1 | $6.18K | Buy |
562
+259
| +85% | +$2.85K | ﹤0.01% | 1747 |
|
|
2022
Q4 | $4.48K | Hold |
303
| – | – | ﹤0.01% | 1820 |
|
|
2022
Q3 | $5K | Buy |
303
+128
| +73% | +$2.11K | ﹤0.01% | 1747 |
|
|
2022
Q2 | $3K | Buy |
+175
| New | +$3K | ﹤0.01% | 1953 |
|